In the Original Investigation titled “Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial” published in the January 21, 2020, issue of JAMA,1 there was incorrect wording in Table 2. The first row in the first column should have read “Primary end point of atrial fibrillation, flutter, or tachycardia.” This article was corrected online.
Reference
- 1.Steinberg JS, Shabanov V, Ponomarev D, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial. JAMA. 2020;323(3):248-255. doi: 10.1001/jama.2019.21187 [DOI] [PMC free article] [PubMed] [Google Scholar]
